Unique ID issued by UMIN | UMIN000007371 |
---|---|
Receipt number | R000008666 |
Scientific Title | Prospective evaluation of renal function and proteinuria in chronic kidney disease patients |
Date of disclosure of the study information | 2012/02/24 |
Last modified on | 2015/09/03 10:13:55 |
Prospective evaluation of renal function
and proteinuria in chronic kidney disease
patients
Prospective evaluation of renal function
and proteinuria in chronic kidney disease
patients (PERFECT study)
Prospective evaluation of renal function
and proteinuria in chronic kidney disease
patients
Prospective evaluation of renal function
and proteinuria in chronic kidney disease
patients (PERFECT study)
Japan |
Proteinuria
Medicine in general | Cardiology | Nephrology |
Adult |
Others
NO
To evaluate the influence which Strong statin has on a renal function to the patient judged that the aggressive lipid fall treatment are required with proteinuria in a single center prospective randomized trial.
Efficacy
Confirmatory
Change of the protein in urine / creatinine ratio after 52 weeks
Change of the protein in urine / creatinine ratio after 26 weeks
Change of the albumin in urine / creatinine ratio
after 26 weeks and 52 weeks
Lipid rate of change
after 26 weeks and 52 weeks
Change of eGFR
after 26 weeks and 52 weeks
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
Numbered container method
3
Treatment
Medicine |
Atorvastatin High capacity group
Atorvastatin normal capacity group
Rosuvastatin group
20 | years-old | <= |
Not applicable |
Male and Female
the protein in urine / creatinine ratio
above 150mg.
Three-month or more administration of the angiotensin converting enzyme inhibitor or angiotensin 2 receptor inhibitor.
the patient judged that the aggressive lipid fall treatment are required.
The patient who caused acute coronary syndrome within six months.
The patient of an inflammatory disorder, infection, and a malignant tumor.
The patient who has an anamnesis of hypersensitivity to atorvastatin
and/or rosuvastatin.
A pregnant woman or the woman that may have become pregnant, and a nursing mother.
A patient with critical impaired liver function and renal dysfunction.
60
1st name | |
Middle name | |
Last name | Masato Watarai |
Aichi welfare agricultural cooperative association
Anjo Kosei Hospital
Division of Cardiology, Department of Internal Medicine
28, Higashihirokute, Anjo-cho, Anjo-shi, Aichi-ken
0566-75-2111
masachi_110@med.nagoya-u.ac.jp
1st name | |
Middle name | |
Last name | Masanori Ito |
Aichi welfare agricultural cooperative association Anjo Kosei Hospital
Division of Cardiology, Department of Internal Medicine
28, Higashihirokute, Anjo-cho, Anjo-shi, Aichi-ken
0566-75-2111
masachi_110@med.nagoya-u.ac.jp
Aichi welfare agricultural cooperative association
Anjo Kosei Hospital
Aichi welfare agricultural cooperative association
Anjo Kosei Hospital
Self funding
NO
2012 | Year | 02 | Month | 24 | Day |
Unpublished
Completed
2012 | Year | 02 | Month | 01 | Day |
2012 | Year | 02 | Month | 01 | Day |
2013 | Year | 12 | Month | 01 | Day |
2013 | Year | 12 | Month | 01 | Day |
2013 | Year | 12 | Month | 01 | Day |
2014 | Year | 03 | Month | 01 | Day |
2012 | Year | 02 | Month | 24 | Day |
2015 | Year | 09 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008666